Ascentage Pharma Group International · Ownership · TradingHolo

Ascentage Pharma Group International · Ownership · TradingHolo

Insider activity

Open-market trades from Form 4 filings

Date	Name	Role	Type	Shares	Value
Thu, 21 May 2026	Yang Dajun	director, officer: Chairman and CEO	M-Exempt	92,746	$0
Thu, 21 May 2026	Yang Dajun	director, officer: Chairman and CEO	M-Exempt	95,575	$0
Thu, 21 May 2026	Zhai Yifan	officer: Chief Medical Officer	M-Exempt	95,575	$0
Thu, 21 May 2026	Zhai Yifan	officer: Chief Medical Officer	M-Exempt	92,746	$0

Institutional holders

From 13F filings · Tue, 30 Jun 2026

Holder	Shares	% out	Change
Point72 Asset Management, L.P.	13,841	0.1%	−2,215
MORGAN STANLEY	919	0.0%	+421
WELLS FARGO & COMPANY/MN	200	0.0%	—
EverSource Wealth Advisors, LLC	24	0.0%	−47
UBS Group AG	15	0.0%	−109
BlackRock, Inc.	6	0.0%	—
Caitong International Asset Management Co., Ltd	1	0.0%	—

Float 6,596,448 · outstanding 23,240,842